The activation and differentiation of peripheral blood T cells (PBT) are known to correlate with increased surface expression and adhesive capacity of ␤ 1 integrins, which mediate adhesion to the extracellular matrix (ECM). However, little is known about the regulation of integrin expression, affinity, and avidity on tissue T cells after they are embedded in the interstitial ECM. In this study we show that tissue T cells, freshly isolated from their residence in the interstitial ECM of the intestinal lamina propria, express a distinct subset of functionally active integrins that contribute to enhanced adhesion to purified collagen, fibronectin, and cell-derived ECM when compared with freshly isolated, short term activated, and long term cultured PBT. Furthermore, integrin usage is distinct between circulating and tissue-derived T cells, in that lamina propria T cells prefer to bind to collagen, while PBT lymphoblasts choose fibronectin when presented with a complex, three-dimensional, cell-derived matrix. To identify the extrinsic factors that regulate the conversion from a nonadhesive PBT to highly adhesive tissue T cell, we demonstrate that activation of PBT in the presence of fibronectin or collagen rapidly generates a surface integrin expression profile, an integrin usage pattern, and adhesive capacity mirroring that of a tissue T cell. These results indicate that the tissue ECM microenvironment instructs newly arrived T cells for further interactions with the underlying matrix and thereby imprints them with a signature tissue adhesive phenotype.
N
aive and memory/effector T lymphocytes continually circulate in search of foreign Ag and rapidly transform from a nonadherent cell while in the blood and lymph to an adherent polarized cell when crawling through tertiary lymphoid organs or inflamed tissues. The recruitment and retention of T lymphocytes within inflamed tissues are dependent on adhesion to an acellular network of proteins, glycoproteins, and proteoglycans known as the extracellular matrix (ECM) 3 (1, 2) . Adhesion is a critical component in a T cell-mediated immune response and is therefore tightly regulated (3) (4) (5) (6) .
Activated effector T lymphocytes mediate immune protection in solid tissue and are thus distinguished from their circulating naive and memory counterparts as a distinct subclass of T cells, the tissue T cell. While T lymphocytes rarely reside in solid tissue of most healthy nonlymphoid organs, the intestinal lamina propria is richly populated with effector CD45RO ϩ T cells (LPT) and is therefore an excellent source of tissue T cells, which are maintained in close physical and functional contact with the surrounding interstitial ECM. This interstitial matrix fills the extracellular space within tissue and serves as a working platform for nonanchored cells. Local fibroblasts synthesize interstitial ECM, which is composed of primarily the glycoproteins fibrillar collagen, fibronectin, tenascin, vitronectin, and proteoglycans (7) . Since LPT possess phenotypic and functional properties distinct from those of naive and memory peripheral blood T cells (PBT) (8, 9) , we propose that the close association of LPT with the ECM might be a mechanism by which the acellular components of tissue modulate the retention and function of tissue T cells.
Adhesive interactions with the ECM microenvironment are mediated by integrins, a large family of heterodimeric glycoproteins composed of noncovalently associated ␣ and ␤ transmembrane subunits. While each ␣␤ heterodimer has its own ligand binding specificity, individual integrins often bind to more than one ligand, and individual ligands are recognized by more than one integrin (10) . T lymphocytes express members of both the ␤ 1 and ␤ 2 integrin families of cell surface adhesion molecules, which mediate cell-ECM and cell-cell interactions, respectively. T cell expression of various ␤ 1 integrin subfamily members mediates binding to components of the interstitial ECM: collagen (␣ 1 ␤ 1 , ␣ 2 ␤ 1 , ␣ 3 ␤ 1 ) and fibronectin (␣ 3 ␤ 1 , ␣ 4 ␤ 1 , ␣ 5 ␤ 1 ) (11) .
T cells rely on integrins to sense and respond to different matrixes, known as outside-in signaling (10) . These interactions initiate intracellular signaling cascades involved in T cell growth, survival, and migration (3, (12) (13) (14) (15) . Conversely, T cells are able to modulate their adhesive phenotype via inside-out signaling by controlling the expression of surface integrins and their relative functional adhesiveness (12) . Integrin-mediated adhesion is regulated at three levels: 1) by cell surface expression (11) , or post-translationally, 2) by changes in integrin affinity for their ligand, attributed to conformational changes in the ligand binding site, and 3) by modulating their avidity via integrin clustering in the plane of the plasma membrane (13, 14) . Thus, integrins exist in several different conformational states. In the closed conformation or inactive state, integrins are unable to bind ligand. A partially active integrin in a low affinity conformation can bind certain ligands, while a fully active integrin, in a high affinity conformation, is readily occupied by ligand (15, 16) .
Circulating blood T cells express moderate amounts of certain ␤ 1 integrins on their cell surface, yet these resting cells adhere poorly to ECM, suggesting that their integrins are expressed in the inactive state (17) . Activation of blood T cells stimulates a rapid augmentation in ␤ 1 -mediated adhesion associated with enhanced integrin affinity and avidity (17) , followed by a slow increase in cell surface expression (11) . Agents that modulate integrin-mediated adhesion in circulating T cells include engagement of the Ag-specific TCR/CD3 complex, CD2, CD7, CD28 costimulation, and chemokines (17) (18) (19) (20) . Increased adhesion can be mimicked in vitro with activating Abs to integrins, divalent cations, and soluble ligand binding, all of which induce rapid dynamic changes in integrin affinity for their ligands (12, 20, 21) , and treatment with phorbol esters, which stimulates integrin clustering and increased avidity (22) . As predicted by these changes after T cell activation, integrin expression and functional status on effector/memory CD45RO ϩ PBT are greater than those in naive CD45RA ϩ PBT (17, 23) . Furthermore, ligation of one subset of integrins regulates the affinity/avidity of another subset of integrins, termed integrin cross-talk (24 -26) .
These previous reports have only evaluated adhesion of PBT to purified protein components of the ECM. In addition, these earlier studies do not address the possibility that PBT may not have been previously exposed to a full complement of matrix proteins either in the blood or in secondary lymph nodes, where some components of the matrix are shielded from lymphocytes by appendages of reticular cells (27, 28) . No studies have addressed whether residence within tissue ECM may modulate T cell adhesion or function. Therefore, we hypothesize that the interstitial ECM microenvironment imprints upon newly arriving blood T cells a signature tissue adhesive phenotype that regulates tissue T cell responses. In this report we use native human intestinal fibroblastderived ECM as well as two of its purified components to investigate the competence and activation requirements of tissue-specific LPT for matrix adhesion. Our studies reveal that freshly isolated LPT adhere strongly to the ECM with or without activation via the ␣ 1 ␤ 1 and ␣ 4 ␤ 1 integrins with a response that is quantitatively and qualitatively distinct from their circulating peripheral blood T cell counterparts. We also demonstrate that although activation of PBT induces the global surface expression of many integrins, neither the distinguishing integrin profile nor the high adhesion of tissue T cells can be mimicked in long term activated PBT. Instead, the distinct adhesiveness of the ␤ 1 integrin family on tissue T cells can be induced in matrix-sheltered PBT by ECM preconditioning, suggesting that a combination of activation and matrix exposure is required for generating a tissue adhesive phenotype. These results demonstrate that naive and memory circulating T cells, once enmeshed within the tissue ECM microenvironment, are imprinted with high affinity and avidity for future interactions with that tissue.
Materials and Methods

Antibodies
For functional studies anti-CD3 mAb OKT3 was purchased from Ortho Diagnostic Systems (Raritan, NJ), and the pair of anti-CD2 Abs T11 2 and T11 3 were a gift from Dr. E. Reinherz (Dana-Farber Cancer Institute, Boston, MA). For immunofluorescence, anti-human fibronectin mAb clone FN-15 (Sigma-Aldrich, St. Louis, MO), rabbit anti-human collagen type I (Accurate Chemicals, Westbury, NY), fluorescein-labeled polyclonal antirabbit (Santa Cruz Biotechnology, Santa Cruz, CA), and Texas Red-labeled polyclonal anti-mouse (Vector Laboratories, Burlingame, CA) were used. For flow cytometry and blocking experiments, anti-human ␣ 1 integrin mAb clone FB12 (Chemicon, Temecula, CA), anti-human integrin ␣ 2 mAb clone P1E6, anti-human integrin ␣ 3 mAb clone P1B5, anti-human integrin ␣ 4 clone P4C2, anti-human integrin ␣ 5 clone P1D6, and anti-human integrin ␤ 1 clone P4C10 were used (Life Technologies, Grand Island, NY). Anti-human CD3 clone UCHT1 and FITC-labeled polyclonal anti-mouse IgG were obtained from DAKO (Carpinteria, CA) and BioSource (Camarillo, CA), respectively.
Isolation and culture of HIF
Human intestinal fibroblasts (HIF) were isolated as described previously (29) . Surgical specimens from patients undergoing bowel resection for colon cancer were washed in calcium-and magnesium-free HBSS (BioWhittaker, Walkersville, MD), and strips of normal mucosa, at least 10 cm from the margin, were dissected, cut into small fragments, and laid on the bottom of scored tissue culture dishes. Medium consisting of DMEM supplemented with 10% heat-inactivated FCS; 2.5% L-glutamine; 1% mixture of penicillin, streptomycin, and fungizone; and 25 mM HEPES buffer (all from BioWhittaker) was added to the dishes, which were incubated at 37°C in humidified 5% CO 2 . Fibroblast growth emanating from the fragments was observed within 3-5 days. At 3-4 wk, subconfluent fibroblasts were detached with a trypsin-versene mixture (BioWhittaker) and established in long term cultures. Cells were fed twice weekly and were split at confluence every 4 -7 days.
Preparation of cell-derived, ECM-coated wells
HIF established from normal donors were grown in flat-bottom, 12-well tissue culture plates (Costar, Cambridge, MA). At confluence, monolayers were maintained in culture for an additional 12 days in the presence of 100 U/ml of human recombinant TNF-␣ (R&D Systems, Minneapolis, MN). Fibroblast monolayers were washed with HBSS and then lysed using 0.5% Triton X-100 (Sigma-Aldrich) in Dulbecco's PBS with calcium and magnesium (DPBS; BioWhittaker) for 10 min, followed by 0.025 N ammonium hydroxide (Fisher Scientific, Hanover Park, IL) for 2 min (30). The resultant native ECM was washed six times with 2 ml of DPBS.
Isolation of lamina propria, PBMC, and T cells
Lamina propria mononuclear cells (LPMC) were isolated as described previously (31) . Briefly, surgical specimens from patients undergoing bowel resection for colon cancer were washed with HBSS. The mucosa was carefully dissected from the underlying submucosa in 5-mm strips and stirred with 10 mM DTT (Sigma-Aldrich) in HBSS for 30 min at room temperature. The tissue then underwent three washes at room temperature in 1 mM EDTA (Sigma-Aldrich), then a series of washes in HBSS to remove the epithelium, followed by an overnight digestion at 37°C, with stirring, in HBSS supplemented with 0.1 mg/ml DNase and 0.1 mg/ml collagenase type 3 (both from Worthington Biochemical Corp., Freehold, NJ) and 2.5% penicillin, streptomycin, and fungizone. Digested tissue was filtered through a 100-m pore size Nitex mesh (Tetko, Lancaster, NY). LPMC were separated by Ficoll-Hypaque density gradient centrifugation (Histopaque; Sigma-Aldrich) at 2000 ϫ g for 5 min at room temperature. For the isolation of PBMC, blood was obtained from healthy volunteers, and PBMC were isolated by Ficoll-Hypaque density gradient centrifugation at 1000 ϫ g for 20 min at room temperature.
To obtain purified LPT and PBT, adherent cells were removed from LPMC or PBMC by plating 30 ϫ 10 6 cells in RPMI 1640 (BioWhittaker) with 5% FCS on 100-mm tissue culture dishes (Corning, Corning, NY) at 37°C in 5% CO 2 for 1 h. Nonadherent cells were collected and incubated for 30 min at 4°C with magnetically labeled anti-CD19, -CD14, and -CD16 Abs (Miltenyi Biotec, Sunnyvale, CA) against B cells, monocytes, and neutrophils, respectively. T cells were negatively selected by MACS. The T cell populations were routinely Ͼ97% CD3 ϩ , as assessed by flow cytometry. The surface phenotypes of freshly isolated LPT and PBT were previously described (32) .
LPT and PBT activation
Freshly isolated LPT and PBT were suspended at 1 ϫ 10 6 cells/ml in RPMI 1640 with 10% FCS alone or with 20 U/ml of human rIL-2 (Chiron, Emeryville, CA), 5 ng/ml PMA, and 500 ng/ml ionomycin (both from SigmaAldrich) or with a 1/1000 dilution of each of the stimulatory anti-CD2 Abs (T11 2 and T11 3 ) and incubated in T25 flasks (Costar) at 37°C in 5% CO 2 for 12 h. Sixty-millimeter tissue culture dishes (Corning) were coated with 2 ml of 10 g/ml anti-CD3 Ab (OKT3) in borate buffer at 37°C for 2 h and washed three times with HBSS. Freshly isolated LPT and PBT were suspended at 1 ϫ 10 6 cells/ml in RPMI 1640 with 10% FCS and stimulated by plate immobilized anti-CD3 Ab for 12 h.
Establishment of T cell lymphoblast lines
Freshly isolated LPMC and PBMC were suspended at 10 6 /ml in RPMI 1640 with 10% FCS containing 1 ng/ml PMA and 0.02% PHA (SigmaAldrich). After 48 h, cells were washed twice and kept at 37°C in 5% CO 2 in RPMI 1640 supplemented with 10% FCS and 20 U/ml of human rIL-2 (Chiron). Lymphoblast cultures were fed twice weekly and used 2 wk later in an adhesion assay with HIF derived native ECM and its purified components. The surface expression of T cell activation markers is similar, as described in an earlier report (33) .
Adhesion assay
Twelve well flat-bottom plates were precoated overnight at 4°C with 12 g/well fibronectin (Chemicon) in DPBS, 40 g/well collagen type I (Sigma-Aldrich) in 0.1 M acetic acid, or 3% BSA (Sigma-Aldrich) in DPBS as a control and then washed three times with DPBS. Freshly isolated T cells or IL-2-derived T cell lines 2 days after passage were fluorescently labeled with 4 M calcein-AM (Molecular Probes, Eugene, OR) for 20 min at 37°C in 5% CO 2 at 2 ϫ 10 6 cells/ml in DPBS containing 5% FCS. The cells were then washed three times with DPBS containing 5% FCS. Calcein-labeled T cells were resuspended in RPMI 1640 without phenol red supplemented with 10% FCS and 5 ϫ 10 5 T cells/well were added to 12-well plates containing HIF-derived native ECM or purified ECM components or to plastic controls for the indicated times. Saturating concentrations of integrin-blocking mAbs (predetermined by flow cytometry) were preincubated with T cells for 30 min at 37°C before adding T cells to the wells for the adhesion assay. Nonadherent cells were removed by a standardized washing technique that was developed to minimize background binding, which includes both an orbital and a rocking motion repeated three times with DPBS. Adhesion was quantified with a multiwell fluorescent spectrophotometer (CytoFluor; PerSeptive Biosystems, Foster City, CA) set for four reads per well at eight sites within the well, which were then averaged for a single reading. For each experimental group the results were expressed as the mean percentage Ϯ SD of bound T cells from triplicate wells.
Flow cytometry
Single-color flow cytometric analysis was performed on freshly isolated T cells and T cell lines. Cells were washed twice in ice-cold DPBS, and 1 ϫ 10 6 cells were resuspended in flow buffer (HBSS containing 1% BSA and 0.1% sodium azide). Cells were incubated with a specific mAb at predetermined saturating concentrations or with isotype-matched nonspecific mouse mAb (DAKO) for 30 min at 4°C, washed twice with flow buffer, and incubated with FITC-conjugated goat anti-mouse IgG for 30 min at 4°C. The cells were again washed twice with flow buffer, fixed in 1% paraformaldehyde, and analyzed by a single laser flow cytometer (EPICS XL-MCL; Beckman Coulter, Fullerton, CA), using WinList software (Topsham, ME). Cells were gated for lymphocytes identified by their specific location in the forward/side scatter diagram, and T cells were identified with anti-CD3. Cells staining with a negative control Ab were gated to contain Ͻ4% positive cells.
PBT preconditioning with collagen type I or fibronectin
Tissue culture dishes (100 mm; Corning) were precoated overnight at 4°C with 30 g/dish fibronectin in DPBS, 100 g/dish collagen type I in 0.1 M acetic acid, or DPBS or 0.1 M acetic acid as a control and were then washed three times with DPBS. Freshly isolated PBT were cultured at 1 ϫ 10 6 cells/ml in RPMI 1640 with 10% FCS alone, with 20 U/ml IL-2-or anti-CD3-coated beads (25 g/ml OKT3) on either control dishes, collagen type I, or fibronectin-coated dishes for 3 days at 37°C in 5% CO 2 . PBT were then removed from the plates with HBSS and used in an adhesion assay or were stained for flow cytometry.
Immunofluorescence microscopy of HIF-derived native ECM
For indirect immunofluorescence analysis 12-well plates containing ECM derived from HIF that had been treated, or not, with TNF-␣ were washed once with DPBS and were blocked with either 3% BSA (Sigma-Aldrich) in DPBS (for collagen type I staining) or 5% horse serum (Vector Laboratories) in DPBS (for fibronectin staining). ECM was then incubated overnight at 4°C with rabbit anti-human collagen type I Ab or mouse antihuman fibronectin in the appropriate blocking buffer. ECM coated with the primary Ab was washed extensively with DPBS and incubated for 60 min at room temperature with a fluorescein-conjugated goat anti-rabbit secondary Ab for collagen type I wells or with a Texas Red-conjugated horse anti-mouse secondary Ab for fibronectin wells (both from Vector Laboratories). Fluorescence microscopy was performed using an IMT-2 inverted microscope (Olympus, Lake Success, NY). Images were acquired with an Olympus camera on 35-mm color slides.
Analysis of data
Statistical analysis was performed using the two-tailed Student's t test and ANOVA (Excel; Microsoft, Redmond, WA). Results are expressed as the mean Ϯ SD, and significance was inferred at p Ͻ 0.05.
Results
Intrinsic adherence of tissue-derived T cells for ECM
To study tissue T cell-matrix interactions we developed a physiologically relevant strategy using cell-derived ECM (native ECM) to investigate the regulation of integrin-mediated adhesion of tissue T cells. The intestinal LPT was chosen as a representative population of tissue lymphocytes that are embedded in the mucosal interstitial ECM produced by HIF. Adhesion of T cells to the native ECM was characterized and quantitated by labeling the cells with calcein, after which 5 ϫ 10 5 cells/well were adhered for 2 h to BSA-coated plastic or native ECM. A representative fluorescent microscopic field after adhesion of freshly isolated LPT is shown in Fig. 1 . In contrast to previous reports showing that PBT are nonadherent to purified components of the ECM (17), there was robust adhesion of freshly isolated tissue T cells to the native matrix and only minimal adhesion to the control. In addition, higher power examination of the adherent cells in Fig. 1A revealed a striking and distinctive change (i.e., spreading) in T cell morphology, directly associated with their interactions with the matrix (data not shown). To quantify the adhesion of tissue T cells for native matrix, the level of adherent T cell fluorescence was measured with a fluorescence spectrophotometer. As shown in Fig. 1B , 41% of calcein-labeled LPT cells adhered to native matrix, whereas Ͻ3% adhered to BSA-coated plastic. Maximal T cell binding to native ECM was observed within 30 min, and this adhesion was stable for Ͼ6 h (data not shown). To demonstrate that the adhesion of tissue T cells to native ECM is predominantly mediated by ␤ 1 integrins, LPT were incubated with a blocking Ab to ␤ 1 before their adherence to native ECM. Inhibition of ␤ 1 interaction with native ECM decreases adhesion by Ͼ90% (Fig. 7) .
Native ECM is composed of a fibrillar network of fibronectin and collagen
The dependence of tissue T cell adhesion on the ␤ 1 family of integrins strongly suggests that both fibronectin and collagen type I are present in the native ECM-derived from mucosal fibroblasts (Fig. 2) . HIF established from normal donors were grown to confluence, and resultant native ECM was prepared. HIF-derived native ECM showed intense staining with Abs against fibronectin (Fig. 2 , bottom left panel) and collagen type I (Fig. 2, bottom right  panel) . The staining pattern indicates the presence of a fibrillar network forming a three-dimensional reticular-like structure. As a control, no fluorescence was detected in wells that were stained with the appropriate secondary Ab alone (Fig. 2, top panels) . These findings together with those of the blocking studies demonstrate that the binding of tissue T cells to native ECM is mediated by the ␤ 1 family of integrins and the production of fibronectin and collagen type I by mucosal fibroblasts.
Tissue T cells express integrins with a higher intrinsic affinity/ avidity for ECM ligands than circulating T cells
As tissue T cells are embedded in the interstitial ECM, we hypothesized that this matrix microenvironment educates the tissue T cell to acquire a specialized adhesiveness for the ECM by shaping a distinctive ␤ 1 integrin expression, affinity, and avidity. To test this hypothesis, freshly isolated unstimulated LPT were adhered for 2 h to native ECM and the two predominant components of this cell-derived ECM, purified collagen type I and fibronectin. As expected, LPT freshly harvested from residence in their ECM-rich microenvironment adhered strongly to all matrixes (Fig. 3 ). In contrast, and in agreement with other reports showing that resting CD4 ϩ blood T cell adhesion to fibronectin and laminin was minimal (17) , freshly isolated PBT adhered poorly (Ͻ6%) to fibronectin, collagen type I, and native ECM. Compared with PBT, the binding of LPT was 4-to 5-fold higher for fibronectin and native ECM and a striking 25-fold higher for collagen type I. Each of these differences between LPT and PBT achieved high significance ( p Ͻ 0.01), demonstrating that interstitial tissue is populated with T lymphocytes that express the ability to adhere. Since collagenase and DNase I were used in the purification of LPT, we treated PBT under identical conditions with these enzymes. The difference in the method of purification does not change the adhesiveness of PBT (data not shown). The observation that LPT binding is significantly greater than PBT adhesion was true over a wide range of fibronectin and collagen type I concentrations (data not shown). These results suggest a distinct pattern of ␤ 1 -mediated adhesion available to tissue T cells due to 1) increased surface expression of appropriate integrins on LPT, 2) enhanced affinity/avidity (i.e., open conformation) of LPT integrins, 3) a different profile of surface integrins, or 4) a combination of all three.
Tissue-derived T cells express a distinct ␤ 1 integrin profile compared with circulating T cells
The increased adhesion of tissue T cells to the ECM suggests that they may express a unique pattern of ␤ 1 integrins. Since T cells use ␣ 3 , ␣ 4 , and ␣ 5 to engage fibronectin and ␣ 1 , ␣ 2 , and ␣ 3 to bind collagen type I (11), we contrasted the surface expression of integrin subunits ␣ 1 to ␣ 5 on LPT vs PBT using single-color flow cytometry (Fig. 4) . Statistical analysis of the mean for four donors revealed that a higher percentage of freshly isolated LPT express the ␣ 1 chain (69%) compared with 16% for PBT ( p Ͻ 0.001). There was also a modest, but significant, increase in the percentage of LPT that express ␣ 3 (56 vs 33%; p Ͻ 0.048), consistent with increased adhesion of LPT for collagen type I. However, high adhesion to fibronectin by LPT was not easily explainable by surface expression of ␤ 1 integrins, since LPT exhibited a dramatic decrease in the percentage of cells expressing ␣ 5 (8 vs 47% for PBT; p Ͻ 0.004), and an identical high percentage expressed the . 4C ) and ␤ 1 (94%; data not shown) chains. Furthermore, greater LPT adhesiveness to ECM was not easily explainable by differences in surface integrin subunit expression on a per cell basis. There was no significant difference in the per cell expression of ␣ 1 , ␣ 2 , and ␣ 3 between PBT and LPT (Fig. 4C) . In fact, the mean fluorescence intensity (MFI) for ␣ 4 and ␣ 5 on PBT was greater than that observed for LPT ( p ϭ 0.019 and 0.001, respectively). Similarly, differences in integrin expression between PBT and LPT were not accountable for by the differences in naive and memory T cell populations. The profiles of ␣ 1 and ␣ 3 expression on CD45 RO ϩ and CD45 RA ϩ PBT were similar and did not reflect the CD45RO ϩ LPT pattern (data not shown). Similarly, ␣ 5 expression was low in LPT and was actually greater in CD45RO ϩ vs CD45RA ϩ PBT (data not shown). Therefore, the enhanced adhesiveness of LPT to native ECM and its components is not simply accountable for by differences in ␤ 1 integrin surface expression, but suggests that integrins on LPT and PBT differ in both their state of activation as well as their unique expression profile.
Short term activation of freshly isolated PBT does not recapitulate LPT adhesiveness
To define the basis for the greater integrin-mediated adhesiveness of LPT, we investigated whether short or long term activation of PBT in the absence of matrix can induce a tissue-like adhesive phenotype and whether these immunological stimuli would alter the adhesiveness of LPT. As reported previously, short term activation of PBT induced an active conformation among ␤ 1 integrins (17, 23, 34, 35) . Freshly isolated PBT were incubated in short term cultures with no stimulus, IL-2, anti-CD2, and plate-immobilized anti-CD3 for 12 h, and then calcein labeled and allowed to adhere to collagen type I, fibronectin, or native ECM (Fig. 5) . Consistent with previous studies, unstimulated PBT were nonadherent for all matrixes, but could acquire the ability to bind to both fibronectin and native ECM weakly with IL-2 and modestly with anti-CD2 or anti-CD3 (Fig. 5B) . In contrast, unstimulated LPT adhered to all matrixes, and stimulation resulted in only a minimal increase in their adhesiveness (Fig. 5A) . PBT did not bind as well as LPT to collagen type I, fibronectin, or native ECM after stimulation with any activator studied, including the strong stimulant PMA/ionomycin (data not shown). The reduced adhesion of freshly isolated (Fig. 4C ) and short term activated (not shown) PBT compared with LPT was not due to less integrin expression per cell. Poor binding of resting and activated PBT to collagen was probably due to the low percentage of cells expressing ␣ 1 and ␣ 2 on their cell surface. While PBT expressed a subset of integrins with the capacity to bind fibronectin and, thus, native matrix, these integrins must be activated by immunological stimuli to engender PBT adherent. Despite a change to an active integrin conformation without a change in surface expression of ␤ 1 integrins (data not shown), the degree of adhesiveness of activated PBT did not approach that of tissue T cells. Furthermore, LPT were strongly adherent both before and after stimulation. These results indicate that tissue T cells, having been previously exposed to interstitial ECM, express a higher intrinsic adhesion for ECM.
The distinct expression of very late Ag (VLA) integrins and the high adhesiveness of tissue T cells for ECM are not attained by long term culture of PBT
Surface expression of ␤ 1 integrins on T cells, i.e., VLA, slowly increases with time during a long period of activation. Therefore, we investigated whether the adhesiveness and integrin profile of PBT in the absence of matrix would approach that of tissue T cells after expansion in culture with IL-2 (Fig. 6 ). Even after PBT were maintained in culture for 2 wk, the profile of VLA integrin expression on PBT lymphoblasts did not replicate the pattern observed with freshly isolated LPT (compare Fig. 6C to Fig. 4A ). In addition, PBT lymphoblast adhesiveness was less than that of similarly cultured LPT (Fig. 6A) . Notably the binding of LPT lymphoblasts was 42 Ϯ 5.4% higher for collagen type I ( p Ͻ 0.04). To investigate whether differences in surface expression of integrin receptors in PBT vs LPT lymphoblasts explain the reduced adhesion of PBT lymphoblasts, we quantified ␣ 1 through ␣ 5 expression by flow cytometry (Fig. 6, B vs C) . Statistical analysis of the mean for four donors revealed that the percentage of T cells expressing ␣ 2 was higher in LPT vs PBT lymphoblasts (86 vs 58%; p Ͻ 0.004), while the percentages of ␣ 1 -, ␣ 3 -, ␣ 4 -, and ␣ 5 -positive T cells were identical. However, on a per cell basis, ␣ 1 surface expression was significantly greater on LPT vs PBT ( Fig. 6D ; p ϭ 0.044), possibly contributing to the greater adhesion of LPT for collagen. Furthermore, the levels of LPT lymphoblast adhesion to both fibronectin and native ECM were 23 Ϯ 11 and 14.1 Ϯ 2.2% higher than that for PBT ( p Ͻ 0.04), respectively. Consistent with this increased binding, on a per cell basis the surface expression of the ␣ 4 fibronectin receptor on the LPT lymphoblast was significantly greater ( p Ͻ 0.007) than that expressed by PBT lymphoblasts (Fig. 6D) . In summary, LPT lymphoblasts express greater levels of VLA-1 and VLA-4 than do PBT lymphoblasts, corresponding to the heightened LPT adhesion to all matrixes (Fig. 6A) . The greatest difference in adhesion between LPT and PBT lymphoblasts, previously observed with freshly isolated T cells, is accentuated on collagen type I matrix. Taken together, these results indicate that the increased adhesiveness of tissue T cells is not due to differences in their state of activation, and that long term culture of PBT in IL-2 does not replicate the integrin expression profile characteristic of the tissue T cell. Thus, tissue T cells may have been instructed by the surrounding interstitial ECM present in their native environment to express a unique adhesiveness, as defined by their integrin profile and conformation.
Distinct integrin usage between tissue and circulating T cells
In light of the persistent differences between tissue and circulating T cells, it is likely that the integrins responsible for mediating their adhesion are distinct. ECM adhesion is mediated by multiple integrins, and conversely, integrins interact with multiple ECM ligands. T cells use ␣ 3 , ␣ 4 , and ␣ 5 to engage fibronectin, and ␣ 1 , ␣ 2 , and ␣ 3 to bind to collagen. We therefore used a panel of functional blocking mAbs to identify the integrins involved in both PBT and LPT adhesion (Fig. 7) . Integrin usage by both LPT and PBT for adhesion to purified collagen type I was similar, predominately mediated by ␣ 1 . In contrast, adhesion to fibronectin was mediated by different integrins. LPT adhesion to fibronectin was entirely mediated by ␣ 4 , while PBT adhesion was markedly predominated by ␣ 5 . Not surprisingly, the integrins responsible for adhesion to native ECM were more complex. When presented with a complex composite matrix, PBT adhesion to the native ECM was mediated by a subset of integrins that recognize fibronectin (i.e., ␣ 4 and ␣ 5 ). On the other hand, tissue T cell adhesion to native matrix was predominated mediated by ␣ 1 and ␣ 2 , integrins that recognize collagen, with a modest contribution of the fibronectin-binding ␣ 4 integrin. These results extend our earlier observations that integrin expression, conformation, and now usage are distinct between tissue and circulating T cells.
Conditioning of fresh PBT with fibronectin or collagen type I dramatically increases their subsequent adhesion to ECM and modulates their integrin usage
The high adhesion of tissue T cells was not emulated by short and long term in vitro activation of PBT in the absence of matrix. Since the ligation of one subset of integrins influences the expression and affinity of another subset of integrins (25, 26, 36, 37) , we predicted that activating PBT in the presence of fibronectin or collagen type I for a short time period (3 days) would increase PBT cell adhesion for ECM. Freshly isolated PBT were cultured with IL-2 in the presence or the absence of fibronectin or collagen type I for 3 days. These PBT were harvested, calcein labeled, and allowed to adhere for 2 h to BSA-coated plastic (control), fibronectin, collagen type I, and native matrix (Fig. 8) . IL-2 activation of PBT in the presence of fibronectin for 3 days nearly doubled the percentage of T cells bound to both fibronectin and native matrix and modestly increased T cell adhesion to collagen type I. Culturing PBT for 3 days in the presence of collagen type I markedly increased the percentage of cells that were able to adhere to fibronectin and native ECM. These findings were similarly replicated with anti-CD3-coated bead stimulation in the presence of matrix (Table I ). An additional feature that distinguishes fresh tissue T cells from fresh circulating PBT is the use of ␣ 5 by LPT and ␣ 4 for PBT adhesion to fibronectin. We therefore investigated whether increased adhesion of fresh PBT to fibronectin following preconditioning coordinated predominantly with ␣ 4 usage ( Table I) . Fresh PBT were preconditioned in the presence of either IL-2 and fibronectin or anti-CD3-coated beads and fibronectin for 3 days, labeled with calcein, and adhered to fibronectin and collagen in the absence and the presence of blocking Abs to the ␣ 1 to ␣ 5 integrins, as described in Fig. 7 . The addition of anti-␣ 4 functional blocking Ab inhibited preconditioned PBT binding to fibronectin by 83%. On the other hand, there was only a minimal ␣ 5 contribution to fibronectin adhesion following preconditioning, as shown by a 15% inhibition in the presence of anti-␣ 5 functional blocking Ab (Table I ). The pattern of preconditioned PBT binding to collagen by ␣ 1 through ␣ 3 was unchanged from that of fresh PBT and fresh LPT (data not shown). The increase in adherence to collagen after collagen preconditioning was particularly striking, with the T cells changing from no detectable adherence to Ͼ60% adherence. Adhesion to fibronectin, collagen type I, and native ECM by collagenpreconditioned PBT equaled or exceeded the strong adhesion noted for freshly isolated and blasted LPT, a level of adhesion we could not achieve for short term (12 h or 3 days) or long term (2 wk) activation in the absence of matrix. These results demonstrate that tissue T cells, which are in constant contact with the interstitial ECM, acquire a distinct adhesive preference and integrin usage pattern from and for their environment. On the other hand, circulating T cells rarely encounter collagen in blood and secondary lymph nodes, thus never acquiring the ability to strongly adhere. However, when these circulating cells do ultimately contact ECM ligands in the tissue, they are imprinted with a distinct adherent tissue phenotype.
Short term activation of PBT in the presence of collagen type I or fibronectin modulates the integrin expression profile, recapitulating the tissue-like T cell phenotype
Adhesion of PBT activated in the presence of components of the ECM, modeling a physiological process, recapitulates the binding of tissue T cells and suggests that the signature integrin profile of tissue T cells may be generated as well. Freshly isolated PBT were activated in the absence or the presence of IL-2, anti-CD3-coated beads, fibronectin, or collagen type I alone and in combination for 3 days. Expression levels of ␣ 1 through ␣ 5 were measured by flow cytometry (Fig. 9) . Marked increases in the expression of ␣ 1 were induced by fibronectin or collagen alone and were further enhanced by coactivation of PBT with IL-2 or anti-CD3 and matrix. ␣ 3 expression was stimulated by collagen alone and more so in combination with IL-2 or anti-CD3. In particular, collagen preconditioning in the presence of IL-2 or CD3 induced ␣ 1 and ␣ 3 expression to levels approaching those of freshly isolated LPT, which paralleled the increase in adhesiveness of the same T cell population (as shown in Fig. 8 ). In support of the role of matrix in educating PBT, we also found that incubation of fresh PBT with fibronectin alone and in combination with anti-CD3 activation, in particular, decreased ␣ 5 expression from 49 to 18%, approaching the low ␣ 5 expression observed in fresh LPT. Reduced expression of ␣ 5 in preconditioned fresh LPT is fully consistent with the functional findings in Table I that demonstrate a shift in integrin usage from ␣ 5 to ␣ 4 . Surface expression of ␣ 2 and ␣ 4 was relatively low and high, respectively (Ͻ10% and ϳ75%, respectively), in a resting PBT. Neither surface expression nor MFI was changed after T cell activation in the presence of matrix protein (data not shown). Therefore, activation of PBT in the presence of newly encountered matrix rapidly transforms these circulating T cells into an adherent lymphocyte, and exposure to fibronectin stimulates a decrease in the expression of the ␣ 5 integrin, resembling that of a tissue T cell freshly isolated from its interstitial microenvironment.
Discussion
The effectiveness of host defense is ultimately gauged by the ability of the host to eliminate infectious agents. Therefore, the final accountability for host survival is dependent on the successful migration and retention of Ag-educated T cells in compromised tissue, which is composed of a fine network of interstitial extracellular matrix. While it is known that T cells acquire receptors that a Freshly isolated PBT were cultured with IL-2 or anti-CD3-coated beads in the presence or the absence of purified fibronectin for 3 days. These PBT were then harvested, calcein labeled, and allowed to adhere for 2 h to BSA-coated plastic as a control or fibronectin.
b Inhibition of adherence in the absence or the presence of blocking mAb specific for ␣ 4 -and ␣ 5 -chains of integrins. Fluorescence of adherent cells was quantified in triplicate using a fluorescence spectrophotometer. Results are the mean percentage in the inhibition of adherence for one representative experiment of three performed. facilitate their tissue-specific extravasation (38 -41) , the signals that orchestrate the selective retention of T cells in infected tissue have not been fully elucidated. Therefore, we define the mechanism by which the nonadherent circulating T cell rapidly differentiates in vitro into the highly adherent tissue T cell. Within 3 days of their initial exposure to collagen and fibronectin, fibrillar components of the ECM, and their re-exposure to Ag, circulating T cells not only express a similar pattern of cell surface integrins as that of tissue-derived T cells, but also exhibit adherence properties that closely resemble those of the tissue T cell. We propose that the interstitial ECM is capable of imprinting upon a newly recruited T cell a signature integrin phenotype that not only assures the long term residence of that T cell in the tissue, but also modulates the longevity and hence the efficacy of an immune response.
The regulation of integrin expression and function is frequently studied on PBL and is commonly accepted to be representative of all T cell subsets (11, 17, 23) . However, the T cell area of lymph nodes is a cellular environment with minimal accessible collagen due to stromal cell processes that sheath the abundant collagen fibers forming the reticular fiber network (27, 28, 42) . In contrast, once an activated T cell enters tissue, it is exposed to Ag again and to interstitial ECM (43, 44) . We demonstrate that tissue T cells, due to residency in an ECM microenvironment, possess differences in their ability to adhere to various ECMs and in their integrin expression profile compared with their circulating counterparts. Our finding that short term activation (12 h) of LPT does not increase their intrinsic high adhesiveness implies that tissue T cells express integrins in an activated or high ligand binding state. This property of tissue T cells is in stark contrast to what we and others show for PBT, whose integrins are expressed in a closed or inactive conformation and upon short term stimulation rapidly acquire modest adherence to both fibronectin and native ECM, but not collagen (17) . In addition, although surface expression of a subset of integrins (␣ 1 , ␣ 2 , ␣ 3 ) is slowly increased in long term activated peripheral blood T cells, leading to their label as VLA (11, 34) , VLA integrin expression is universally increased in long term cultured PBT and bears little resemblance to the profile of ␤ 1 integrins on tissue T cells extracted from their residence in the ECM. Furthermore, the heightened affinity of integrins expressed by tissue T cells to components of the ECM is unattainable by these long term activated circulating blood T cell. In addition, the extended length of in vitro culture required for the appearance of these VLA integrins (i.e., 14 days) is inconsistent with the 3-5 days observed for the redistribution and accumulation of activated T cells into tissues in mouse models (41) .
While tissue T cells derived from the intestinal mucosa differentially express the ␤ 7 family of integrins, adhesion to the ECM is mediated predominantly by ␤ 1 integrins, as evidenced by the blocking of T cell adhesion by neutralizing Abs directed against ␤ 1 (Fig. 7) . It was previously reported that the state of T cell differentiation, memory vs naive, modulates the expression and functional status of integrins (23) . Memory T cells express 3-to 4-fold more ␣ 4 and ␣ 5 than do naive cells and bind more efficiently to fibronectin (17) . However, CD45RO
ϩ tissue LPT express 7-to 8-fold more ␣ 1 , 20-fold more ␣ 3 , and 7-fold less ␣ 5 than do CD45RO ϩ PBT (data not shown). In addition, a larger percentage of CD45RO
ϩ LPT adhere to both fibronectin and collagen than what was reported for CD45RO ϩ PBT (17) . These results demonstrate that the tissue origin of T cells is the over-riding determinant of the adhesive phenotype, more so than the state of T cell activation and differentiation.
Tissue LPT express a significantly different profile of ␤ 1 integrins compared with that on short term activated and long term cultured PBT. An increased percentage of tissue T cells bear integrins mediating adhesion to collagen (␣ 1 and ␣ 3 ), explaining their greater adhesion to collagen. Thus, these findings support our premise that exposure to ECM contributes to the distinct tissue T cell integrin adhesive phenotype. Our hypothesis is further supported in vivo, in that the number of resident lymphocytes in the intestine is reduced by 50% in the VLA1-deficient mouse (45) , suggesting that the ␣ 1 ␤ 1 integrin is required to support the retention of T cells in the interstitial matrix in the gut. In addition, freshly isolated tissue LPT express ␣ 4 in an active conformation, mediating their adherence to fibronectin despite their lack of surface expression of ␣ 5 . It was reported that migration of activated PBT on fibronectin is mediated by ␣ 5 ␤ 1 , and that suppressing ␣ 4 ␤ 1 activity enhanced the level of migration (26) . We propose that the high expression of ␣ 4 and loss of ␣ 5 on resident tissue T cells decrease their mobility and thus increase their long-term retention.
When PBT are activated for only 3 days in the presence of collagen or fibronectin, their ability to adhere to different matrixes, their surface integrin expression, and their integrin usage pattern recapitulate those of the tissue T cell, respectively. Activation of PBT in the presence of fibronectin preconditions these cells for enhanced binding to both fibronectin and native ECM, but not FIGURE 9. Preconditioning PBT in the presence of ECM rapidly imprints a distinct integrin surface expression, mirroring a tissue phenotype. Freshly isolated PBT were cultured in medium alone, IL-2, or suboptimal concentrations of anti-CD3 in the absence of matrix or the presence of purified fibronectin or collagen type I for 3 days. Flow cytometric analysis was performed on these preconditioned lymphoblasts for ␣ 1 through ␣ 5 surface expression. A, Representative histograms of four experiments for ␣ 1 (f, medium alone; Ⅺ, anti-CD3 plus collagen), ␣ 3 (f, medium alone; Ⅺ, anti-CD3 plus collagen), and ␣ 5 (f, medium alone; Ⅺ, anti-CD3 plus fibronectin) surface expression are shown. Negative control cells were gated to contain Ͻ3% positive cells, allowing for the determination of a quantitative modulation of ␣ 1 (B), ␣ 3 (C), and ␣ 5 (D) surface expression.
collagen, and induces the distinctive decrease in expression of ␣ 5 , with a concomitant increase in ␣ 4 -mediated adhesion, a hallmark of the tissue-derived T cell. Therefore, we conclude that a fibronectin-rich microenvironment for PBT modifies integrin surface expression and affinity of those integrins that mediate adhesion to fibronectin and promotes a tissue T cell phenotype. In adherent cells, integrin binding can result in the generation of outside-in signals that modulate the function and expression of integrins (26, 36, 37) . Preconditioning PBT in the presence of collagen stimulates the expression of ␣ 1 and ␣ 3 to levels equivalent to those observed on tissue T cells and induces optimal adhesion to fibronectin, collagen, and native ECM compared with cells activated in the presence of fibronectin. We propose that as the newly extravasated PBT enters the tissue, its expression of ␣ 5 permits its migration deep into the matrix. Subsequently, exposure to interstitial collagen stimulates increased expression of ␣ 1 and ␣ 3 coupled with an increase in cell adhesion. Once completely embedded, fibronectin stimulates the down-regulation of ␣ 5 , transforming the migratory, newly recruited T cell to a static, defensive tissue T cell, and collagen crafts a highly adherent cell. Therefore, tissue cells are imprinted with the capacity for adherence to matrix, which may be one mechanism by which these cells establish and maintain residency within their tissue microenvironment.
Our results also underscore the need to fully assess the impact of the native matrix on T cells, since both collagen and fibronectin are needed to imprint a tissue adhesive and an integrin phenotype, respectively, on an activated PBT. Furthermore, when PBT lymphoblasts are presented with native matrix containing both collagen and fibronectin, they exclusively adhere to fibronectin despite expressing all VLA molecules. Similarly, when LPT encounter native matrix, they preferentially bind to collagen despite exhibiting complete binding to purified fibronectin. These results, which truly reflect the biologically relevant T cell adhesive response, highlight the critical differences between adhesion complexes formed with two-dimensional substrates and the narrowed integrin usage we observe with a cell-derived three-dimensional matrix (46) . While a full chemical, structural, and functional evaluation of the native ECM is beyond the scope of this report, our results highlight the importance of considering both the topology and the composition of the ECM as an immunoregulatory mediator.
T cells isolated from their residency in tissue are routinely identified as effector/memory cells. Yet, one important characteristic of the tissue T cell has often been overlooked. Tissue T cells are intimately associated with the ECM during Ag exposure, cytokine stimulation, and cell migration. This study extends the function for the ECM beyond its classic structural role in tissue architecture to imprint upon the extravasating blood T cell its adaptation to its new home within the tissue interstitium. First exposure to ECM rapidly alters the integrin phenotype of the newly arrived cell, optimizing its ability to assume residence within its new microenvironment. It therefore seems likely that the ECM may also regulate other T cell responses within tissue, thereby assuming an active role in modulating T cell morphology, polarization, proliferation, and effector function.
